^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Suprefact (buserelin acetate)

    i
    Other names: Hoe 766, S-746766
    Associations

    News

    Trials
    Company:
    Sanofi
    Drug class:
    GnRH agonist
    Related drugs:
    Associations

    News

    Trials
    over2years
    Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial (clinicaltrials.gov)
    P3, N=2478, Recruiting, NRG Oncology | Suspended --> Recruiting | Trial completion date: Dec 2038 --> Dec 2033
    Enrollment open • Trial completion date
    |
    CD4 (CD4 Molecule)
    |
    bicalutamide • Erleada (apalutamide) • triptorelin • goserelin acetate • flutamide • Firmagon (degarelix) • leuprolide acetate for depot suspension • Suprefact (buserelin acetate)